Velcalcetide
(Difference between revisions)
Ossip Groth (Talk | contribs) m (→Wikipedia) |
Ossip Groth (Talk | contribs) m (→Mechanism of action) |
||
Line 6: | Line 6: | ||
==Mechanism of action== | ==Mechanism of action== | ||
− | {{ | + | {{slink| |t=Velcalcetide for secondary hyperparathyroidism – first line|l=http://www.hsric.nihr.ac.uk/topics/velcalcetide-for-secondary-hyperparathyroidism-first-line/|usr=goo}} |
{{tp|p=26290606|t=Critical Cysteine Residues in Both the Calcium-Sensing Receptor and the Allosteric Activator AMG 416 Underlie the Mechanism of Action |pdf=http://molpharm.aspetjournals.org/content/early/2015/08/19/mol.115.098392.full.pdf|usr=|}} | {{tp|p=26290606|t=Critical Cysteine Residues in Both the Calcium-Sensing Receptor and the Allosteric Activator AMG 416 Underlie the Mechanism of Action |pdf=http://molpharm.aspetjournals.org/content/early/2015/08/19/mol.115.098392.full.pdf|usr=|}} | ||
{{tp|p=23674604|t=Pharmacology of AMG 416 (Velcalcetide), a novel peptide agonist of the calcium-sensing receptor, for the treatment of secondary hyperparathyroidism in hemodialysis patients |pdf=|usr=|}} | {{tp|p=23674604|t=Pharmacology of AMG 416 (Velcalcetide), a novel peptide agonist of the calcium-sensing receptor, for the treatment of secondary hyperparathyroidism in hemodialysis patients |pdf=|usr=|}} |
Revision as of 06:51, 1 September 2015
- HOP_Nephrology_Index shows all Nephrology topics
- All re-compiled topics
Moremed Velcalcetide Etelcalcetide+OR+{AMG_416}+OR+{KAI_4169}+OR+{ONO_5163}+OR+Telcalcetide+OR+Velcalcetide
Velcalcetide, a novel calcimimetic, is an allosteric activator of casr, the calcium sensitizing receptor and is in development to treat secondary hyperparathyreoidism of chronical renal failure in a way similar to cinacalcet.
Contents |
Mechanism of action
Weblink noncommercial {{{c}}} |
Velcalcetide for secondary hyperparathyroidism – first line |
Journal article, free access |
GET Critical Cysteine Residues in Both the Calcium-Sensing Receptor and the Allosteric Activator AMG 416 Underlie the Mechanism of Action Extract PDF direct |
Journal article, free access |
GET Pharmacology of AMG 416 (Velcalcetide), a novel peptide agonist of the calcium-sensing receptor, for the treatment of secondary hyperparathyroidism in hemodialysis patients Extract [ PDF direct] |
Journal article, free access |
GET Comparison of AMG 416 and cinacalcet in rodent models of uremia Extract PDF direct |
Journal article, free access |
GET Velcalcetide (AMG 416), a novel peptide agonist of the calcium-sensing receptor, reduces serum parathyroid hormone and FGF23 levels in healthy male subjects Extract PDF direct |
Journal article, free access |
GET AMG 416 (velcalcetide) is a novel peptide for the treatment of secondary hyperparathyroidism in a single-dose study in hemodialysis patients Extract [ PDF direct] |
Mentioned in Fulltext
Journal article, free access |
GET The use of fibroblast growth factor 23 testing in patients with kidney disease Extract PDF direct |
Journal article, free access |
GET Longitudinal FGF23 and Klotho axis characterization in children treated with chronic peritoneal dialysis Extract PDF direct |
Journal article, free access |
GET Calcimimetics and outcomes in CKD Extract PDF direct |
Trials
Wikipedia
Wikipedia |
en-wiki |
Books